Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1988-01-26
1989-12-19
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
558430, 558432, 558433, 558434, A61K 31275, C07C12146
Patent
active
048883573
ABSTRACT:
Disclosed herein are novel .beta.-cycloalkyl-.beta.-oxopropionitriles which exhibit anti-inflammatory/antiarthritic activities.
REFERENCES:
patent: 3016295 (1962-01-01), Davidson et al.
patent: 3406183 (1968-10-01), Laliberte
patent: 4061767 (1977-12-01), Ertel et al.
patent: 4170656 (1979-10-01), Hanifin, Jr. et al.
patent: 4173650 (1979-11-01), Hanifin, Jr. et al.
patent: 4189436 (1980-02-01), Hanifin et al.
patent: 4197310 (1980-04-01), Hanifin, Jr. et al.
patent: 4254047 (1981-03-01), Hanifin, Jr. et al.
patent: 4254048 (1981-03-01), Hanifin, Jr. et al.
patent: 4254049 (1981-03-01), Hanifin, Jr. et al.
patent: 4256759 (1981-03-01), Walker
patent: 4435407 (1984-05-01), Walker
patent: 4644010 (1987-02-01), Walker
J. Med. Chem., 1979, 22:1385-9; Ridge, et al.
Chem. Abst. (1929), 23:4193; Pabst.
Bristol-Myers Company
Brust Joseph Paul
Yang Mollie M.
LandOfFree
Antiarthritic .beta.-cycloalkyl-.beta.-oxopropionitriles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiarthritic .beta.-cycloalkyl-.beta.-oxopropionitriles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarthritic .beta.-cycloalkyl-.beta.-oxopropionitriles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1903193